Healthcare Services

A key trend shaping the Fecal Microbiota Transplantation (FMT) Market involves the Advancements In Standardized Microbiota-Based Therapeutics

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Valuation Is Forecasted For The Fecal Microbiota Transplantation (FMT) Market By 2030 Starting From Its 2026 Size?

The fecal microbiota transplantation (fmt) market size has expanded significantly in recent years. It is anticipated to increase from $0.91 billion in 2025 to $0.98 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.1%. The historical growth of this market can be linked to the acknowledgment of the gut microbiome’s influence in disease, the effectiveness of fmt in treating recurrent cdi cases, the proliferation of hospital-based fmt initiatives, early regulatory directives concerning microbiome therapies, and the accessibility of stool banks.

The fecal microbiota transplantation (fmt) market is projected to experience robust expansion in the coming years. By 2030, its value is anticipated to reach $1.27 billion, exhibiting a compound annual growth rate (CAGR) of 6.8%. This projected growth can be attributed to factors such as expanded research into microbiome-derived treatments, a growing need for standardized fmt products, the broadening of therapeutic applications beyond digestive disorders, increased financial commitment to microbiome biotechnology, and advancements in oral drug delivery methods. Key trends during this period involve stricter standardization of donor screening procedures, a greater uptake of cryopreserved fmt solutions, wider clinical endorsement extending beyond CDI treatment, the proliferation of capsule-based administration techniques, and a sharpened emphasis on analyzing the microbiome.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19430&type=smp

Which Market Drivers Are Supporting The Expansion Of The Fecal Microbiota Transplantation (FMT) Market?

The increasing occurrence of gastrointestinal conditions is projected to boost the expansion of the fecal microbiota transplantation (FMT) market moving ahead. Gastrointestinal (GI) disorders encompass various health issues impacting the entire gastrointestinal tract, comprising the esophagus, stomach, small intestine, large intestine (colon), rectum, and anus. This surge in gastrointestinal disorders stems from heightened stress levels, inactive routines, and greater intake of processed foods. Fecal microbiota transplantation finds application in gastrointestinal disorders to reinstate beneficial gut bacteria, particularly in managing recurring Clostridioides difficile infections. For example, data from Crohn’s and Colitis Canada, a Canada-based non-profit organization, indicated that in 2023, the count of individuals in Canada with IBD was rapidly growing, moving from 322,600 in 2023 (representing 0.8% of the population) to an estimated 470,000 by 2035 (or 1.1% of the population). Furthermore, in 2023, 11,000 individuals were diagnosed (equating to 1 every 48 minutes), a figure anticipated to climb to 14,000 by 2035 (or 1 every 38 minutes). Consequently, the growing incidence of gastrointestinal disorders fuels the growth of the fecal microbiota transplantation (FMT) market.

Which Segment Categories Define The Fecal Microbiota Transplantation (FMT) Market?

The fecal microbiota transplantation (fmt) market covered in this report is segmented –

1) By Type: Fermentation, Fresh, Cryopreservation

2) By Donor Type: Stool-Derived, Fecal-Derived, Whole-Microbiome Derived

3) By Indication: Clostridioides Difficile Infection, Inflammatory Bowel Disease, Metabolic Syndrome, Other Indications

4) By Administration Route: Oral, Rectal, Nasogastric, Colon Capsule

5) By End-User: Hospitals, Specialty Clinics, Other End-Users

Subsegments:

1) By Fermentation: Fermented FMT Products, Fermented Capsules, Fermented Liquids, In-House Fermentation Techniques

2) By Fresh: Fresh Stool Samples, Fresh FMT Capsules, Fresh FMT Solutions for In-Hospital Use, Freshly Prepared FMT for Outpatient Use

3) By Cryopreservation: Cryopreserved Stool Samples, Cryopreserved FMT Capsules, Cryopreserved Liquid FMT, Long-Term Storage Solutions for Cryopreserved FMT

Which Trends Are Shaping The Future Of The Fecal Microbiota Transplantation (FMT) Market?

Major companies operating in the fecal microbiota transplantation (FMT) market are prioritizing the adoption of standardized microbiota-based therapies, such as fecal microbiota spores, live-brpk, to boost safety, patient compliance, treatment consistency, and overall scalability. Fecal microbiota spores, live-brpk are highly processed microbial spores derived from donors, manufactured under stringent screening and purification procedures, intended to restore healthy gut microbiota through controlled dosing and a reduced risk of infection. For instance, in April 2023, Seres Therapeutics, a US-based microbiome therapeutics company, secured FDA approval for VOWST. This fecal microbiota spores, live-brpk therapy is designed to prevent the recurrence of Clostridioides difficile infection in adults, distinguished by its oral capsule delivery, defined microbial spore composition, and rigorous pathogen-screening protocols. VOWST significantly enhances treatment convenience, safety, and commercial scalability within the FMT sector.

Who Are The Top Companies Competing In The Fecal Microbiota Transplantation (FMT) Market?

Major companies operating in the fecal microbiota transplantation (fmt) market are Ferring Pharmaceuticals, Johns Hopkins Medicine, Seres Therapeutics, Taconic Biosciences, Enterome, Rebiotix Inc, Finch Therapeutics Group Inc, Locus Biosciences, Yeda Research and Development Co. Ltd, Microbiotica Limited, CosmosID Inc, AOBiome, Synthetic Biologics Inc., Osel Inc., OpenBiome, Asia Microbiota Bank, Taymount Clinic, MicroBiome Therapeutics LLC, MaaT Pharma SA, Kallyope

Read the full fecal microbiota transplantation (fmt) market report here:

https://www.thebusinessresearchcompany.com/report/fecal-microbiota-transplantation-fmt-global-market-report

How Is The Fecal Microbiota Transplantation (FMT) Market Distributed Across Key Geographic Regions?

North America was the largest region in the fecal microbiota transplantation (FMT) market in 2025. The regions covered in the fecal microbiota transplantation (fmt) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Fecal Microbiota Transplantation (FMT) Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19430&type=smp

Browse Through More Reports Similar to the Global Fecal Microbiota Transplantation (FMT) Market 2026, By The Business Research Company

Bone Marrow Transplantation Global Market Report

https://www.thebusinessresearchcompany.com/report/bone-marrow-transplantation-global-market-report

Hematopoietic Stem Cell Transplantation Global Market Report

https://www.thebusinessresearchcompany.com/report/hematopoietic-stem-cell-transplantation-global-market-report

Transplant Diagnostics Global Market Report

https://www.thebusinessresearchcompany.com/report/transplant-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795